| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8580514 | Primary Care Diabetes | 2018 | 19 Pages |
Abstract
Emerging data suggests that with SGLT2 inhibition, renal function seems to be preserved in people with diabetes with or without renal impairment. Furthermore, SGLT2 inhibition prevents further renal function deterioration and death from kidney disease in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Samuel Seidu, Setor K. Kunutsor, Xavier Cos, Syed Gillani, Kamlesh Khunti, For and on behalf of Primary Care Diabetes Europe For and on behalf of Primary Care Diabetes Europe,